TD Asset Management Inc Sells 313,361 Shares of Encompass Health Corporation $EHC

TD Asset Management Inc decreased its position in Encompass Health Corporation (NYSE:EHC) by 23.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,025,852 shares of the company’s stock after selling 313,361 shares during the quarter. TD Asset Management Inc’s holdings in Encompass Health were worth $125,800,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of EHC. GAMMA Investing LLC lifted its position in Encompass Health by 21.5% in the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock worth $240,000 after buying an additional 419 shares during the last quarter. Fifth Third Bancorp lifted its position in Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company’s stock worth $434,000 after buying an additional 2,017 shares during the last quarter. QRG Capital Management Inc. lifted its position in Encompass Health by 2.2% in the 1st quarter. QRG Capital Management Inc. now owns 15,930 shares of the company’s stock worth $1,613,000 after buying an additional 341 shares during the last quarter. State of Alaska Department of Revenue lifted its position in Encompass Health by 2.5% in the 1st quarter. State of Alaska Department of Revenue now owns 13,006 shares of the company’s stock worth $1,316,000 after buying an additional 315 shares during the last quarter. Finally, Guided Capital Wealth Management LLC bought a new stake in Encompass Health in the 1st quarter worth approximately $2,096,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. UBS Group boosted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Bank of America boosted their price objective on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. KeyCorp boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Tuesday, September 16th. Finally, Truist Financial boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $139.86.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $122.95 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The company has a market cap of $12.38 billion, a PE ratio of 24.06, a P/E/G ratio of 2.12 and a beta of 0.93. The business has a 50 day moving average of $123.14 and a 200 day moving average of $116.80. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.86.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. Encompass Health’s dividend payout ratio is currently 14.87%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.